Phosphorus Counting Table for the control of serum phosphorus levels without phosphate binders in hemodialysis patients

被引:3
作者
Bertonsello-Catto, Vivianne Reis [1 ]
Lucca, Leandro Junior [2 ]
Cardeal da Costa, Jose Abrao [3 ]
机构
[1] Univ Sao Paulo, Dept Clin Med, Grad Program Sci, Ribeirao Preto Med Sch, Sao Paulo, Brazil
[2] Univ Sao Paulo, Dept Clin Med, Nephrol Div, CKD MBD Unit,Ribeirao Preto Med Sch, Sao Paulo, Brazil
[3] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Clin Med, Nephrol Div, Sao Paulo, Brazil
关键词
Chronic kidney disease; Hyperphosphatemia; Phosphorus dietary; Renal dialysis; Food and nutrition education; MANAGEMENT; MORTALITY; CALCIUM; HYPERPHOSPHATEMIA; ASSOCIATION; METABOLISM; PRODUCT; DISEASE; DIET; RISK;
D O I
10.1016/j.clnesp.2019.03.008
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background and aims: Hyperphosphatemia constitutes one of the major problems faced by patients with chronic kidney disease, and nourishment plays a significant role in its control. The present study aimed to evaluate the maintenance of phosphorus serum levels by observing measurements before and after an intervention using the Phosphorus Counting Table (PCT), in hemodialysis patients lacking phosphate binder use. Methods: The assessment included fifty individuals on hemodialysis who underwent phosphate binder suspension 30 days prior to the intervention. The participants received food and nutrition education on the PCT tool, which assists in the control of dietary phosphorus intake, and followed its instructions for two months. Fasting blood samples were collected at three moments for phosphorus, total calcium, and parathyroid hormone (PTH) analysis. The study sample was initially analyzed as a whole, then sub-classified into two groups: adherence and non-adherence. Results: At the end of the study, no significant difference in serum phosphorus was observed in the total and the adherence groups (p > 0.05). The non-adherence group showed a substantial increase of 0.74 mg/dL in serum phosphorus levels and 6.16 mg(2)/dL(2) in the calcium-phosphorus product after the intervention. Meanwhile, the calcium-phosphorus product improved from 56.42 +/- 11.49 mg(2)/dL(2) to 51.05 +/- 10.67 mg(2)/dL(2) in the adherence group. Serum calcium levels did not change throughout the study in the three groups. A significant increment in PTH serum levels was observed at the end of the study in all groups. Conclusion: The PCT showed to be efficient in the maintenance of serum phosphorus in the individuals who adhered well to the tool, without the administration of phosphate binders. Such a method can assist in patient adherence to treatment and enables better diet flexibility. (C) 2019 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 50 条
[11]   Association of dietary phosphate and serum phosphorus concentration by levels of kidney function [J].
Moore, Linda W. ;
Nolte, Joy V. ;
Gaber, A. Oscuna ;
Suki, Wadi N. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2015, 102 (02) :444-453
[12]   CALCIUM ACETATE CONTROL OF SERUM PHOSPHORUS IN HEMODIALYSIS-PATIENTS [J].
EMMETT, M ;
SIRMON, MD ;
KIRKPATRICK, WG ;
NOLAN, CR ;
SCHMITT, GW ;
CLEVELAND, MV .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (05) :544-550
[13]   Association of Dietary Phosphorus Intake and Phosphorus to Protein Ratio with Mortality in Hemodialysis Patients [J].
Noori, Nazanin ;
Kalantar-Zadeh, Kamyar ;
Kovesdy, Csaba P. ;
Bross, Rachelle ;
Benner, Debbie ;
Kopple, Joel D. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (04) :683-692
[14]   Lanthanum Carbonate Provides Control of Phosphorus Levels in Patients New to Phosphate Binder Therapy and Patients Changed From Other Phosphate Binders [J].
Noto, Linda .
JOURNAL OF RENAL NUTRITION, 2011, 21 (03) :277-282
[15]   European hemodialysis patient satisfaction with phosphate binders is associated with serum phosphorus levels: the Dialysis Outcomes and Practice Patterns Study [J].
McCullough, Keith ;
Port, Friedrich K. ;
de Sequera, Patricia ;
Rayner, Hugh ;
Pecoits-Filho, Roberto ;
Walpen, Sebastian ;
Evenepoel, Pieter ;
Pisoni, Ronald L. .
CLINICAL KIDNEY JOURNAL, 2021, 14 (08) :1886-1893
[16]   Additional Reduction in Serum Phosphorus Levels by Pulverized Lanthanum Carbonate Chewable in Hemodialysis Patients [J].
Yamashita, Tetsuri ;
Ogawa, Tetsuya ;
Takahashi, Masaki ;
Mitsuhashi, Tetsuya ;
Shizuku, Junichi ;
Takahashi, Naoshi ;
Ohba, Takashi ;
Miyajima, Sayako ;
Kabaya, Takashi ;
Otsuka, Kuniaki ;
Nitta, Kosaku .
THERAPEUTIC APHERESIS AND DIALYSIS, 2013, 17 :54-59
[17]   Serum Phosphorus Levels are Associated with Intradialytic Hypotension in Hemodialysis Patients [J].
Yang, Kyung Hoon ;
Cho, Seong ;
Kim, Sung Rok ;
Lee, Yu-Ji .
NEPHRON, 2021, 145 (03) :238-244
[18]   Phosphate binder pill burden, adherence, and serum phosphorus control among hemodialysis patients converting to sucroferric oxyhydroxide [J].
Gray, Kathryn ;
Ficociello, Linda H. ;
Hunt, Abigail E. ;
Mullon, Claudy ;
Brunelli, Steven M. .
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2019, 12 :1-8
[19]   An Optical Method for Serum Calcium and Phosphorus Level Assessment during Hemodialysis [J].
Holmar, Jana ;
Uhlin, Fredrik ;
Fernstrom, Anders ;
Luman, Merike ;
Jankowski, Joachim ;
Fridolin, Ivo .
TOXINS, 2015, 7 (03) :719-727
[20]   Challenge of phosphorus control in hemodialysis patients: a problem of adherence? [J].
Dolores Arenas, Maria ;
Malek, Tamara ;
Teresa Gil, Maria ;
Moledous, Analia ;
Alvarez-Ude, Fernando ;
Reig-Ferrer, Abilio .
JOURNAL OF NEPHROLOGY, 2010, 23 (05) :525-534